Respirix
2024 Revenue
$607.3K(Est.)
Funding
$0
Team
4
Founded
2015
Respirix Revenue (2024)
Developer of a portable device designed to monitor cardiac health. The company's portable device offers proprietary insights into the pulmonary vasculature non-invasively and aims to address both at-home monitoring and critical care applications in categories such as heart failure and hemodynamics, enabling patients to obtain reproducible measurements independent of interpatient variability with little to no subject training required.
Last updated
Respirix Revenue
In 2024, Respirix's revenue reached $607.3K. The company previously reported $627.4K in 2023.
| Year | Milestone | Source |
|---|---|---|
| 2024 | Respirix Hit $607.3k revenue in October 2024 | Estimated |
| 2023 | Respirix Hit $627.4k revenue in December 2023 | Estimated |
| 2021 | Respirix Hit $653.5k revenue in April 2021 | |
| 2015 | Launched with $0 revenue |
Respirix Valuation, Funding Rounds
Explore the complete funding history and valuation milestones for this company. Below you will find information about each funding round and key financial metrics that shaped the company's growth trajectory.
| Year | Round | Amount | Valuation | % Sold | Source |
|---|
Founder / CEO
Daniel Burnett
CEO
A physician-inventor, Daniel Burnett founded Respirix, the San Francisco company behind Cardiospire, a handheld device that monitors heart failure non-invasively by reading cardiogenic oscillations in exhaled airflow. He earned MD and MBA degrees from Duke University after studying bioengineering at the University of Pennsylvania, and runs TheraNova, the San Francisco medical device incubator he launched in 2005 that has spun out more than a dozen companies. Burnett is named on dozens of issued patents and directs UCSF's Masters of Translational Medicine program as an adjunct professor.
Customers
We do not have customer count information for Respirix yet.
Respirix Employees & Team Size
Respirix employs approximately 4 people as of 2026.
| Year | Milestone | Source |
|---|---|---|
| 2024 | Reached 4 employees (October 2024) | |
| 2023 | Reached 4 employees (December 2023) | |
| 2022 | Reached 5 employees (December 2022) | |
| 2021 | Reached 5 employees (December 2021) | |
| 2021 | Reached 8 employees (April 2021) |
Frequently Asked Questions about Respirix
What is Respirix's revenue?
Respirix generates an estimated $607.3K in annual revenue.
Who founded Respirix?
Respirix was founded by Daniel Burnett.
Who is the CEO of Respirix?
The CEO of Respirix is Daniel Burnett.
How many employees does Respirix have?
Respirix has 4 employees.
Where is Respirix headquarters?
Respirix is headquartered in San Francisco, California, United States.
Data and Sources
All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.
Claim this profilePeople Also Viewed
Veritus Agent
AI agents for the consumer lending industry
QuarterOne
Developer of a sales forecasting application intended to help small businesses who need real-time...
HiCustomer
Developer of a customer success management platform intended to act as an engine for business...
Vox AI
Vox AI: Automates drive thru experiences using AI
XO Capital
Buy and grow SaaS companies
SAFA
SAFA is a pre-revenue B2B SaaS company being spun out of the University of Notre Dame, automating...
